{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:34:44Z","timestamp":1773916484044,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/s101560170023","type":"journal-article","created":{"date-parts":[[2002,10,15]],"date-time":"2002-10-15T10:53:15Z","timestamp":1034679195000},"page":"255-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis"],"prefix":"10.1016","volume":"7","author":[{"given":"Satoshi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaoki","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Hisasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s101560170023_bib0805","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archinte.159.1.53","article-title":"Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections, a prospective randomized clinical trial","volume":"159","author":"Mombelli","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1007\/s101560170023_bib0810","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01973737","article-title":"Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis","volume":"9","author":"Sandberg","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1007\/s101560170023_bib0815","first-page":"S216","article-title":"Evaluation of new anti-infective drugs for the treatment of urinary tract infection","volume":"15","author":"Rubin","year":"1990","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s101560170023_bib0820","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprimsulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women, a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1007\/s101560170023_bib0825","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(98)00160-5","article-title":"Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis","volume":"52","author":"Richard","year":"1998","journal-title":"Urology"},{"key":"10.1007\/s101560170023_bib0830","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000007280","article-title":"Changes in susceptibility of Pseudomonas aeruginosa to gatifloxacin and carbapenem in an in vitro urinary bladder model","volume":"46","author":"Takahashi","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1007\/s101560170023_bib0835","doi-asserted-by":"crossref","first-page":"649","DOI":"10.5980\/jpnjurol1928.78.4_649","article-title":"Urinary \u03b22-microglobulin level and urinary N-acetyl-\u03b2-d-glucosaminidase activity in acute pyelonephritis patients","volume":"78","author":"Tanaka","year":"1987","journal-title":"Jpn J Urol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X0171255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X0171255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s101560170023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:42:53Z","timestamp":1761158573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X0171255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001]]}},"alternative-id":["S1341321X0171255X"],"URL":"https:\/\/doi.org\/10.1007\/s101560170023","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s101560170023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}